Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase

被引:105
作者
Kaplan, M
Aviram, M [1 ]
机构
[1] Rambam Med Ctr, Lipid Res Lab, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Bruce Rappaport Fac Med, Lipid Res Lab, IL-31096 Haifa, Israel
关键词
atherosclerosis; oxidized LDL; macrophage; inflammation; antioxidants; paraoxonase;
D O I
10.1515/CCLM.1999.118
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Oxidative stress and inflammatory processes are of major importance in atherogenesis because they stimulate oxidized LDL (Ox-LDL)-induced macrophage cholesterol accumulation and foam cell formation, the hallmark of early atherosclerosis. Under oxidative stress, both blood monocytes and plasma lipoproteins invade the arterial wall, where they are exposed to atherogenic modifications. Oxidative stress stimulates endothelial secretion of monocyte chemoattractant protein 1 (MCP-1) and of macrophage colony stimulating factor (M-CSF), leading to monocyte adhesion and differentiation, respectively. LDL binds to extracellular matrix (ECM secreted by endothelial cells, smooth muscle cells and macrophages) proteoglycans, in a process that contributes to the enhanced susceptibility of the lipoprotein to oxidation by arterial wall macrophages. ECM-retained Ox-LDL is taken up by activated macrophages via their scavenger receptors. This leads to cellular cholesterol accumulation and enhanced atherogenesis. Protection of LDL against oxidation by antioxidants that can act directly on the LDL, or indirectly on the cellular oxidative machinery, or conversion of Ox-LDL to a non-atherogenic particle by HDL-associated paraoxonase (PON-1), can contribute to attenuation of atherosclerosis.
引用
收藏
页码:777 / 787
页数:11
相关论文
共 121 条
[1]   MONOCYTIC ORIGIN OF FOAM CELLS IN HUMAN ATHEROSCLEROTIC PLAQUES [J].
AQEL, NM ;
BALL, RY ;
WALDMANN, H ;
MITCHINSON, MJ .
ATHEROSCLEROSIS, 1984, 53 (03) :265-271
[2]   LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants [J].
Aviram, M ;
Fuhrman, B .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 188 (1-2) :149-159
[3]   Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein [J].
Aviram, M ;
Kent, UM ;
Hollenberg, PF .
ATHEROSCLEROSIS, 1999, 143 (02) :253-260
[4]  
AVIRAM M, 1995, ISRAEL J MED SCI, V31, P241
[5]   MODIFIED FORMS OF LOW-DENSITY-LIPOPROTEIN AND ATHEROSCLEROSIS [J].
AVIRAM, M .
ATHEROSCLEROSIS, 1993, 98 (01) :1-9
[6]  
Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
[7]   Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein [J].
Aviram, M ;
Rosenblat, M ;
Etzioni, A ;
Levy, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (09) :1069-1079
[8]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[9]   Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis [J].
Aviram, M ;
Fuhrman, B .
ATHEROSCLEROSIS, 1998, 137 :S45-S50
[10]  
AVIRAM M, 1994, J LIPID RES, V35, P385